Cell therapy weekly: experimental solid cancer CAR-T approved for clinical testing
Cell therapy weekly: experimental solid cancer CAR-T approved for clinical testing regmednet.com
Онкология
Иммунотерапия и CAR-T
185 материалов по теме, собраны автоматически из проверенных источников
Онкология
From Immunotherapy to “Smart” Drugs: Which Technologies Have Transformed Cancer Treatment Over the Past 10 Years
From Immunotherapy to “Smart” Drugs: Which Technologies Have Transformed Cancer Treatment Over the Past 10 Years UA.NEWS
Онкология
От иммунотерапии до «умных» лекарств: какие технологии изменили лечение рака за последние 10 лет
От иммунотерапии до «умных» лекарств: какие технологии изменили лечение рака за последние 10 лет UA.NEWS
🎗️
Онкология
Ученые выявили ген, истощающий иммунные клетки при онкологии и усиливающий эффективность иммунотерапии
Ученые выявили ген, истощающий иммунные клетки при онкологии и усиливающий эффективность иммунотерапии Gosrf.ru
Онкология
Scientists find the gene that drives T-cell exhaustion, revealing new strategy to improve immune responses
Immunotherapy, which uses a patient's immune system to treat disease, has increased survival for some adults and children with cancer. However, it has had limited success against many pediatric solid tumors, in part because T cells can become functionally impaired or "exhausted." St. Jude Children's Research Hospital…
Онкология
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research Yahoo Finance
Онкология
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research PR Newswire
Онкология
Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer
Pancreatic cancer does not respond to most immunotherapies, but RAS inhibitors could alter tumors to make them more sensitive to a novel immunotherapeutic approach. In pancreatic tumors with RAS mutations, RAS inhibitors cause massive cell death and reduce immunosuppression. These changes tend to be temporary because…
Онкология
Immunotherapy increases risk for major cardiovascular events
Treatment with immune checkpoint inhibitors can significantly increase risk for major adverse cardiovascular events among patients with cancer, including heart failure, myocardial infarction and stroke. A retrospective analysis of more than 30,000 patients showed individuals treated with immune checkpoint inhibitors…
Онкология
New Immunotherapy Strategy Extends KRAS Inhibitor Response in Pancreatic Cancer
New Immunotherapy Strategy Extends KRAS Inhibitor Response in Pancreatic Cancer Inside Precision Medicine
Онкология
Sophie Gray-Gaillard Advances Research on T Cells and Cancer Immunotherapy – PICI
Sophie Gray-Gaillard Advances Research on T Cells and Cancer Immunotherapy – PICI Oncodaily
Онкология
Rheumatic immune-related adverse events with immune checkpoint inhibitors more severe than previously reported
For patients receiving immune checkpoint inhibitors (ICIs), rheumatic immune-related adverse events (rh-irAEs) are usually moderate or severe, with more than one-third leading to permanent ICI discontinuation, according to a study published online Sept. 8 in ACR Open Rheumatology.
Онкология
Zolbetuximab and Immunotherapy Across PD-L1 CPS in Advanced Gastric and GEJ Cancer
Zolbetuximab and Immunotherapy Across PD-L1 CPS in Advanced Gastric and GEJ Cancer Oncodaily
Онкология
How immunotherapy changed cancer treatment – and why its impact is still growing
How immunotherapy changed cancer treatment – and why its impact is still growing UT MD Anderson
🎗️
Онкология
Bringing Innovation Closer to Home: Expanding Access to Immunotherapy Through Community Oncology
Bringing Innovation Closer to Home: Expanding Access to Immunotherapy Through Community Oncology ASCO Connection